Susan Kramer has more than 30 years experience in biopharmaceutical research and development, with the first 18 at Genentech.

She was a co-founder of Corthera, Inc., subsequently acquired by Novartis, and has held senior management and key alliance management roles at a number of biotech companies, including XOMA, Anesiva and Annexon Biosciences. She most recently served as Executive Vice President of Development at Concentric Analgesics. She has led development teams for both protein and small molecule therapeutics in the US and globally.

Dr. Kramer received a BA from College of St. Scholastica, an MA in Education from Central Michigan University and earned her MPH and DrPH in Biomedical Sciences (Virology) from the University of California Berkeley. She has served on numerous science and education boards and committees.